Daniel J Coleman Selected Research

Therapeutics

1/2022	PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia.
7/2019	Molecular Testing Identifies Determinants of Exceptional Response and Guides Precision Therapy in a Patient with Lethal, Treatment-emergent Neuroendocrine Prostate Cancer.
6/2016	Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor.
5/2014	Retinoid-X-receptors (α/β) in melanocytes modulate innate immune responses and differentially regulate cell survival following UV irradiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel J Coleman Research Topics

Disease

9	Neoplasms (Cancer) 01/2020 - 04/2010
7	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 06/2016
3	Adenocarcinoma 01/2021 - 07/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2020
2	Leukemia 01/2022 - 01/2020
2	Breast Neoplasms (Breast Cancer) 07/2019 - 02/2016
2	Melanoma (Melanoma, Malignant) 01/2015 - 05/2014
1	Ovarian Neoplasms (Ovarian Cancer) 07/2019
1	Epidermal Cyst (Sebaceous Cyst) 11/2017
1	Cysts 11/2017
1	Disease Progression 06/2016
1	Glioblastoma (Glioblastoma Multiforme) 02/2016
1	Weight Loss (Weight Reduction) 02/2016

Drug/Important Bio-Agent (IBA)

6	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 06/2016
3	enzalutamideIBA 01/2021 - 06/2016
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2020
2	Phenobarbital (Luminal)FDA Link 01/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 07/2019 - 01/2019
2	Retinoid X Receptors (Retinoid X Receptor)IBA 11/2017 - 05/2014
1	Histone DemethylasesIBA 01/2020
1	Lysine (L-Lysine)FDA Link 01/2020
1	Poly Adenosine Diphosphate RiboseIBA 07/2019
1	PlatinumIBA 07/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2019
1	DNA (Deoxyribonucleic Acid)IBA 07/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2019
1	ChromatinIBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Keratins (Keratin)IBA 11/2017
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2017
1	AndrogensIBA 06/2016
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2016
1	Biological ProductsIBA 02/2016
1	coibamide AIBA 02/2016
1	DepsipeptidesIBA 02/2016
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2015
1	Retinoid X Receptor alphaIBA 01/2015
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 05/2014
1	SwainsonineIBA 04/2010
1	alpha-Mannosidase (LAMAN)IBA 04/2010

Therapy/Procedure

5	Castration 01/2019 - 06/2016
4	Therapeutics 01/2022 - 05/2014
1	Drug Therapy (Chemotherapy) 07/2019